All Articles

A new Montreal-based collaboration aims to use advanced AI and a unique dataset to make drug development faster, smarter, and safer for patients.

Bit Digital reports a $147M paper loss on its ETH, pivots to riskier DeFi yields, and leans on its AI venture as a strategic counterbalance.

Two of Yemen's top banks partner with IFI for advanced compliance training, a critical move to build trust and navigate global sanctions in a fragile state.

A new partnership brings a cost-effective B100 biodiesel solution to the Netherlands, offering fleets an immediate way to slash carbon emissions.

The firm adds veteran TD Cowen analyst Boris Peaker to deepen its research in oncology and genetic medicines, signaling a major bet on specialized insight.

King Resources unwinds a major collectibles acquisition, canceling over 62 million shares after items failed to sell, raising questions about market risks.

Furniture giant Ashley launches its premium Ashley Luxe line with Hailee Steinfeld, a bold move into the competitive 'affordable luxury' market.

New AI tools from Penguin Ai on Snowflake Marketplace aim to automate prior authorization and medical coding, targeting billions in administrative waste.

FOX News is integrating Kalshi's real-time prediction market data, a move that could revolutionize news but sparks debate over accuracy and ethics.

Avaí Bio and Austrianova are set to present new findings on a novel cell-based therapy designed to produce the 'longevity protein' Klotho.

Two Canadian giants join forces, bringing No Frills and Superstore to your door via Skip. What this means for Instacart, Walmart, and your wallet.

Celebrating four decades, HMA excels by helping self-funded employers control rising healthcare costs through a blend of strategic insight, tech, and service.

A new device from Agiliti aims to prevent painful and costly pressure injuries during surgery, a problem that affects millions and costs billions annually.

In a major strategic move, Premier Research appoints Paul Spreen as CCO, signaling a bold push to capture the rebounding biotech market.

The new algorithm aims to systematically filter out harmful interactions and reduce hidden trading costs in the complex world of off-exchange trading.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

A new AI software that analyzes MRI scans has received a first-of-its-kind FDA classification, promising to help doctors differentiate complex brain disorders.

A new trial for advanced liver cancer tests visugromab, a drug aiming to overcome immunotherapy resistance and reverse debilitating cancer-related wasting.

Canadian energy giant Pembina unveils its '3Cs' strategy, targeting data centers and LNG while promising disciplined 5-7% annual growth for investors.

TriNetX's acquisition of Zetta Genomics' XetaBase platform promises to accelerate research by integrating genomic and clinical data on a global scale.